| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology, 2 Institute for Neuropathology, and 3 Institute of Medical Microbiology and Hygiene, University of Mainz, Mainz, Germany.
PURPOSE. To determine the presence of activated complement components in eyes affected by diabetic retinopathy.
METHODS. Eyes of 50 deceased donors with diabetic retinopathy and of 10 nondiabetic subjects with uveal melanoma (n = 6) or phthisical eyes (n = 4), as well as eyes of 16 deceased donors without diabetic retinopathy were subjected to immunohistochemical studies, using a panel of antibodies directed against candidate markers of complement activation.
RESULTS. Extensive deposits of complement C5b-9 complexes were detected in the choriocapillaris immediately underlying the Bruch membrane and densely surrounding the capillaries, in all 50 diabetic retinopathy specimens. Complement deposition was sometimes also observed around the larger choroidal vessels. Similarly intense staining for C5b-9 was absent in 25 of the 26 of the other donor eyes. Positive staining was observed in a case of systemic amyloidosis. Staining for C3d positively correlated with C5b-9 staining, corroborating the notion that complement activation had occurred in situ. Furthermore, positive staining was found for vitronectin, which forms stable complexes with extracellular C5b-9. When present, deposits under the pigment epithelium and drusen also stained positively for the activated complement components, independent of diabetic retinopathy. In contrast, there was no positive staining for C-reactive protein (CRP), mannose-binding lectin (MBL), C1q, or C4, indicating that complement activation did not occur through a C4-dependent pathway.
CONCLUSIONS. The presence of C3d, C5b-9, and vitronectin indicates that complement activation occurs to completion, possibly through the alternative pathway in the choriocapillaris in eyes affected by diabetic retinopathy. Complement activation at this site may evoke a spectrum of pathologic sequelae that could contribute to ocular tissue disease and visual impairment.
This article has been cited by other articles:
|
|
 |
|
  S. Hakobyan, C. L. Harris, C. W. van den Berg, M. C. Fernandez-Alonso, E. G. de Jorge, S. R. de Cordoba, G. Rivas, P. Mangione, M. B. Pepys, and B. P. Morgan Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein J. Biol. Chem., November 7, 2008; 283(45): 30451 - 30460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Simo, M. Higuera, M. Garcia-Ramirez, F. Canals, J. Garcia-Arumi, and C. Hernandez Elevation of Apolipoprotein A-I and Apolipoprotein H Levels in the Vitreous Fluid and Overexpression in the Retina of Diabetic Patients Arch Ophthalmol, August 1, 2008; 126(8): 1076 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Seth, J. Cui, E. To, M. Kwee, and J. Matsubara Complement-Associated Deposits in the Human Retina Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 743 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jha, J.-H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU). J. Immunol., June 15, 2006; 176(12): 7221 - 7231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Bora, J.-H. Sohn, J. M. C. Cruz, P. Jha, H. Nishihori, Y. Wang, S. Kaliappan, H. J. Kaplan, and N. S. Bora Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization J. Immunol., January 1, 2005; 174(1): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
